The Past, Present, Future
Over the past 10 years, the present knowledge and defining the future priorities for Alternating Hemiplegia of Childhood (AHC) and ATP1A3 diseases
This unique event will be a journey of discovery in Alternating Hemiplegia of Childhood (AHC) and ATP1A3 diseases since the gene discovery 10 years ago………Where have we come from, where have we reached, and what is next?
It will incorporate the 10-year anniversary conference of AHC & ATP1A3 diseases and the 10th Symposium on ATP1A3 in disease
When: Wednesday 19th– Friday 21st October 2022
Where: Hybrid event | Edinburgh (The Royal College of Physicians of Edinburgh Conference Centre) and ONLINE
Sessions will cover:
- AHC and ATP1A3 diseases – where are we now and where are we going?
- Collaborative science – the ATP1A3 community and what it has brought
- Sharing current research on AHC and ATP1A3 diseases: the life-course clinical perspective
- Key dilemmas for clinicians, researchers, and families
- Back to the lab – the latest updates on AHC & ATP1A3 diseases advances in research
- Driving forward research and understanding in rare diseases: how can patients and families be involved in research?
- Driving forward knowledge in AHC and ATP1A3 diseases: how can learning from patients and families improve clinical care?
- Moving forwards with research: clinical trials
- Moving forwards with research: gene therapy strategies
More information on all the sessions will be released in the coming weeks with the full programme
Keynote plenary speaker
In recognition of the 10- year anniversary since the ATP1A3 gene discovery for AHC and ATP1A3 diseases, we are delighted to announce:
Professor Kathleen Sweadner
‘ATP1A3 disease –phenotypic description to gene discovery’
Plenary talk discussing the basic science perspective of the gene discovery
The full programme, speakers and all presentations will be released shortly
Here is a taster, including presentations and discussion on (more topics and information to follow):
- Future research priorities for families (and those with the lived experience of the diseases) and researchers/clinicians
- Addressing the genotype-phenotype correlation in AHC and ATP1A3 diseases
- ATP1A3 mutations cause polymicrogyria
- Transition from childhood to adulthood
- AHC – a lifelong disease. Long-term follow-up of adults with AHC
- Sleep issues in AHC and ATP1A3 diseases
- Updates from TREAT AHC research study– What drugs are being tried?
- ATP1A3 expression: spinal cord/motor function
- Patient-driven registries
- How to engage patients for faster transfer of research results to clinical practice
- Preparing for clinical trials in AHC and ATP1A3 diseases
- Updates in gene therapy research for AHC & ATP1A3 diseases
Researchers/Clinicians Booking link: https://tinyurl.com/10YEARSATP1A3
Family Booking link: please contact email@example.com